ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Diagnosis, Prevention, And Treatment Of Cardiovascular Diseases With Genome Editing

Completed
Institution
University of Pennsylvania, PA
Principal investigator
Kiran Musunuru
Funding
$813K
Duration
2019–2026
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY For the past 6 years, my independent laboratory has leveraged new approaches in human genomics and pioneered new types of post-genomic functional studies—empowered by genome-editing technologies—to elucidate novel mechanisms that drive cardiovascular diseases. My laboratory has characterized the roles of specific genes involved in lipid metabolism, coronary heart disease, and diabetes, as well yielding insights into how noncoding DNA variation influences the functions of these genes. Going forward, my research will take advantage of recent advances in disease modeling and therapeutic genome editing—advances in which my laboratory played a part—to tackle two exemplary translational challenges in the cardiovascular field: (1) the use of therapeutic genome editing to prevent coronary heart disease, the leading cause of death worldwide; and (2) the use of genome editing to empower high-throughput functional annotation of variants of uncertain significance detected in patients by clinical sequencing.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER35ZHL1-CSR-I(O2)coronaryeditinggenomegenome editingcardiovascular diseasesheart diseasecardiovascularcoronary heart

Questions for University of Pennsylvania

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.